Gene · 833
Papers4,113
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 4,113
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Imaging CAR-NK cells targeted to HER2 ovarian cancer with human sodium-iodide symporter-based positron emission tomography. | Eur J Nucl Med Mol Imaging | 2024 | 38722382 | PubTator, text mining | PubMed |
Scrutiny of chimeric antigen receptor activation by the extracellular domain: experience with single domain antibodies targeting multiple myeloma cells highlights the need for case-by-case optimization. | Front Immunol | 2024 | 38720898 | PubTator, text mining | PubMed |
| Rapid response in relapsed follicular lymphoma to novel anti-CD19 CAR-T therapy with pseudo-progression and cytomegalovirus infection: A case report. | Int Immunopharmacol | 2024 | 38703571 | PubTator, text mining | PubMed |
| Development of a compact bidirectional promoter-driven dual chimeric antigen receptor (CAR) construct targeting CD19 and CD20 in the Sleeping Beauty (SB) transposon system. | J Immunother Cancer | 2024 | 38677881 | PubTator, text mining | PubMed |
| Identification of the ferroptosis-related prognostic gene signature in mesothelioma. | Gene | 2024 | 38670397 | PubTator, text mining | PubMed |
| Extracellular domains of CARs reprogramme T cell metabolism without antigen stimulation. | Nat Metab | 2024 | 38658805 | PubTator, text mining | PubMed |
| Exploring the efficacy and safety of anti-BCMA chimeric antigen receptor T-cell therapy for multiple myeloma: Systematic review and meta-analysis. | Cytojournal | 2024 | 38628287 | PubTator, text mining | PubMed |
| Discovery and preclinical development of a therapeutically active nanobody-based chimeric antigen receptor targeting human CD22. | Mol Ther Oncol | 2024 | 38596311 | PubTator, text mining | PubMed |
| INSPIRED Symposium Part 5: Expanding the Use of CAR T Cells in Children and Young Adults. | Transplant Cell Ther | 2024 | 38588880 | PubTator, text mining | PubMed |
| Magnetic CAR T cell purification using an anti-G4S linker antibody. | J Immunol Methods | 2024 | 38574803 | PubTator, text mining | PubMed |
| In vitro re-challenge of CAR T cells. | Methods Cell Biol | 2024 | 38548418 | PubTator, text mining | PubMed |
| CRISPR, CAR-T, and NK: Current applications and future perspectives. | Genes Dis | 2024 | 38545126 | PubTator, text mining | PubMed |
| Chimeric antigen receptors: "CARs" in the fast lane for rheumatology. | Curr Opin Rheumatol | 2024 | 38517338 | PubTator, text mining | PubMed |
| Integration of ζ-deficient CARs into the CD3ζ gene conveys potent cytotoxicity in T and NK cells. | Blood | 2024 | 38493479 | PubTator, text mining | PubMed |
| Screening and diagnostic tools for autism spectrum disorder: Systematic review and meta-analysis. | Clinics (Sao Paulo) | 2024 | 38484581 | PubTator, text mining | PubMed |
| Differential protein-protein interactions underlie signaling mediated by the TCR and a 4-1BB domain-containing CAR. | Sci Signal | 2024 | 38442200 | PubTator, text mining | PubMed |
| Mechanical forces amplify TCR mechanotransduction in T cell activation and function. | Appl Phys Rev | 2024 | 38434676 | PubTator, text mining | PubMed |
| An endoscopic scoring system for achalasia: the CARS score. | Gastrointest Endosc | 2024 | 38431105 | PubTator, text mining | PubMed |
| Approaches for bridging therapy prior to chimeric antigen receptor T cells for relapsed/refractory acute lymphoblastic B-lineage leukemia in children and young adults. | Haematologica | 2024 | 38356450 | PubTator, text mining | PubMed |
| Mutation-specific CAR T cells as precision therapy for IGLV3-21R110 expressing high-risk chronic lymphocytic leukemia. | Nat Commun | 2024 | 38307904 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/833/papers?page=8